Shanghai Huilun Pharmaceutical reports new angiotensin AT2 receptor antagonists

CellThe critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM

FierceBiotechPE firm Altaris scoops up AI drug development outfit Simulations Plus for $375M

BioPharma DiveLilly buys non-opioid pain drugmaker 4E

BioPharma DiveExpress Scripts, PCMA sue to block Tennesee law breaking up PBMs and pharmacies

BioPharma DiveFDA staff scrutinizes evidence supporting Moderna’s flu vaccine

Endpoints NewsEdgewise to advance heart drug into Phase 3 following mid-stage data update

FierceBiotechEdgewise data power rival to BMS and Cytokinetics toward phase 3

FierceBiotechiRhythm hit by cyberattack that compromised patient data, says operations unaffected

FierceBiotechMerck inks $510M biobucks data generation partnership with Protillion

Endpoints NewsHow to launch a telehealth business in one day

Endpoints NewsLilly buys another pain biotech; FDA sets decision for once-weekly PrEP pill

PharmaVoiceCorvus CEO thinks his next blockbuster is an ITK inhibitor